Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback